Proportional (qualifier value)	3
survival aspects	5
Clinical (qualifier value)	1
Multicenter Trials	1
regimen	2
Blood Platelets	1
High dose (qualifier value)	1
performance status	1
cooperative group	1
Lumbar (qualifier value)	2
Neoplasms	1
Second (qualifier value)	1
German population	1
Lithium	3
With quality (attribute)	1
Leucovorin Calcium	7
Increased (qualifier value)	1
Median Statistical Measurement	2
DOS	1
Rectum	1
Entire rectum	1
Continuance of life	5
Intravascular line	2
Linear	2
Overall [Publication Type]	1
Result (navigational concept)	1
proven venom	1
With frequency	1
DNA Topoisomerase	1
Surgery specialty	1
hazard	1
Previous (qualifier value)	2
Israel	1
Degree or extent	1
Low (qualifier value)	1
week (qualifier value)	2
Common (qualifier value)	1
social resistance	1
criteria	1
Cell Division	1
Liquid substance	3
Human Development	1
Academic degree	1
Time	6
Preferences (qualifier value)	1
Life Expectancy	1
Combined (qualifier value)	1
Histologic	1
Crossed (qualifier value)	1
Office	1
Neutropenia	1
Phase (qualifier value)	1
Frequency of Responses	3
History of (contextual qualifier) (qualifier value)	1
Secondary malignant neoplasm of liver (disorder)	1
random assignment	1
Room of building - Study	1
Additive (qualifier value)	2
Therapeutic procedure	3
Age (qualifier value)	1
Recording of previous events	1
Lights, manufactured	3
Questionnaires	1
Light color	3
CHOOSING	1
Following (attribute)	1
Primary operation (qualifier value)	1
Significant (qualifier value)	2
Pharmaceutical Preparations	1
Neoplasm Metastasis	2
pharmacotherapeutic	2
Lighter, device (physical object)	3
Cancer treatment response rate	3
Resistance (Psychotherapeutic)	1
Surgical aspects	1
ADVANTAGE	1
Hemoglobin G (substance)	1
Two (qualifier value)	1
Responses	1
South Africa	1
Ratio (property) (qualifier value)	1
Euphoric mood	2
Population	1
III (qualifier value)	1
Cancer resistance to treatment	1
Same (qualifier value)	2
Assessment procedure (procedure)	1
First (qualifier value)	2
development aspects	1
Left (qualifier value)	3
Random Allocation	2
Light	3
Long (qualifier value)	1
Primary	1
Scientific Study	1
High	2
MST	1
Groups (qualifier value)	11
Absolute neutrophil count	1
Group (social concept)	10
Effect (qualifier value)	1
therapeutic aspects	3
Chemotherapy, Adjuvant	1
Timing (attribute)	2
Duration	2
Secondary malignant neoplastic disease (disorder)	1
history	1
irinotecan	10
benefits	1
Alanine Transaminase	1
Medical History	1
Lighting	3
One (qualifier value)	1
GENERAL OPERATIVE PROCEDURES	1
Adenocarcinoma	1
Median (qualifier value)	2
Patients	6
Diarrhea	1
Pharmacotherapy	2
L (qualifier value)	3
Weekly (qualifier value)	1
Secondary to	1
Research Personnel	1
Liquid (finding)	3
year (qualifier value)	1
LAB ABNORMALITY	1
Metastatic to	1
standard therapy	1
Proven findings	1
History of (present illness) (contextual qualifier) (qualifier value)	1
Fluorouracil	3
Variable (qualifier value)	1
ENDPOINT	2
Differential (qualifier value)	1
Timed (qualifier value)	2
Toxic effect	3
Countries (geographic location)	1
Most (qualifier value)	1
Chemotherapy-Oncologic Procedure	2
Synchronous (qualifier value)	1
